Pfizer found a way to boost its ailing stock — agree on drug pricing with TrumpRx

September 30, 2025

https://images.mktw.net/im-09462434

Last Updated: Sept. 30, 2025 at 7:10 p.m. ET
First Published: Sept. 30, 2025 at 2:27 p.m. ET

Shares of Pfizer Inc. powered higher Tuesday after the drug giant announced a “voluntary” agreement to meet several of President Donald Trump’s demands to lower drug prices for Americans.

The company

PFE said it would lower U.S. drug prices to match those of other developed countries, which was a key point of contention for the Trump administration, and the reasoning behind the executive order Trump signed in May that instituted a “most favored nation” policy for prescription drugs.

This post was originally published on Market Watch

Futurist Eric Fry says it will be a “Summer of Surge” for these three stocks

One company to replace Amazon… another to rival Tesla… and a third to upset Nvidia. These little-known stocks are poised to overtake the three reigning tech darlings in a move that could completely reorder the top dogs of the stock market. Eric Fry gives away names, tickers and full analysis in this first-ever free broadcast.

Watch now…